|Published (Last):||22 November 2008|
|PDF File Size:||6.29 Mb|
|ePub File Size:||19.78 Mb|
|Price:||Free* [*Free Regsitration Required]|
ISSN X. The Antiphospholipids Syndrome SAF , is a disease of the immune system, in which antibodies with apparent specificity by phospholipids with negative electrical charge exist. Its incidence of all the Thrombosis illness is from a 3.
Present hypotheses would explain its pathogenic action based on the activation of endothelial cells; the oxidation damage of endothelium vascular cells and the modulation of the coagulation. The presentation forms are given by greater and smaller clinical criteria, where the substrate is the thrombosis events and a ominous obstetrical history. The diagnostic is confirmed with laboratory examinations, with antibodies measurement, serological test.
The control must be frequent, by multidisciplinary medical team. Two clinic's cases of pregnancy and SAF are presented. Keywords : Antiphospholipids syndrome ; pregnancy. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Services on Demand Journal. How to cite this article.
Síndrome antifosfolipídico y embarazo
Antiphospholipid syndrome APS carries a risk of thrombosis and infertility. Consequently the use of any type of hormone therapy and pregnancy in APS requires special considerations. The present article provides a broad review of all these issues. The use of contraception, hormone replacement therapy and selective estrogen receptor modulators in APS are described. Lastly, the possible fetal and maternal complications that can occur during pregnancy are described and, based on the literature, recommendations for the management of pregnancy in women with APS are provided.. ISSN: X.